Copper ions are needed for several hallmarks of
cancer. However, the involved pathways, mechanisms, and
copper-
binding proteins are mostly unknown. We recently found that cytoplasmic
Antioxidant 1
copper chaperone (Atox1), which is up-regulated in
breast cancer, is localized at the lamellipodia edges of aggressive
breast cancer cells. To reveal molecular insights into a putative role in cell migration, we here investigated
breast cancer cell (MDA-MB-231) migration by video microscopy as a function of Atox1. Tracking of hundreds of individual cells (per condition) over a 9-h time series revealed that cell migration velocity and directionality are significantly reduced upon Atox1 silencing in the cells. Because silencing of the
copper transporter ATP7A also reduced cell migration, these
proteins appear to be on the same pathway, suggesting that their well-known
copper transport activity is involved. In-cell proximity
ligation assays demonstrated that Atox1, ATP7A, and the
proenzyme of
lysyl oxidase (LOX;
copper-loaded via ATP7A) are all in close proximity and that LOX activity is reduced upon Atox1 silencing in the cells. Since LOX is an established player in
cancer cell migration, our results imply that Atox1 mediates
breast cancer cell migration via coordinated
copper transport in the ATP7A-LOX axis. Because individual cell migration is an early step in
breast cancer metastasis, Atox1 levels in
tumor cells may be a predictive measure of
metastasis potential and serve as a
biomarker for
copper depletion
therapy.